Real-World Effectiveness of First-Line Osimertinib Versus Amivantamab-Based Regimens in EGFR-Mutated NSCLC: A Multicenter Comparative Outcome Study
Research Article Real-World Effectiveness of First-Line Osimertinib Versus Amivantamab-Based Regimens in EGFR-Mutated NSCLC: A Multicenter Comparative Outcome Study Emily R. Thompson, Daniel…